China officially joins global vaccine initiative COVAX

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • Are they frozen jellyfish?
  • Huge stockpile of WWI artillery grenades found in North Macedonia
  • Millions in U.S. defy warnings against Thanksgiving holiday travel
  • CGTN published this video item, entitled “China officially joins global vaccine initiative COVAX” – below is their description.

    For more: Apart from pledging to make Chinese-made vaccines a global public good, #China has joined #COVAX, an international #COVID-19 vaccine initiative, which aims to ensure equitable distribution worldwide of COVID-19 vaccines. The collaboration focuses on middle- and lower-income countries that cannot fully afford them.

    CGTN YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Trump pardons former National Security Adviser Michael Flynn
  • Belgium to become a distribution hub for coronavirus vaccines across Europe and Africa
  • Federal opposition ‘trying to play partisan politics’ over stranded Australians
  • There’s So Much to Be Thankful for, Right?
  • A mistake to allow states to ‘determine their own’ international quarantine caps: Clennell
  • Leave a Comment